Functional analyses confirmed that TG7 promotes tumor cell proliferation, and that its silencing using DsiRNA3 led to a dose-dependent reduction in cell viability, accompanied by the upregulation of pro-inflammatory cytokines IL6 and TNFα, as well as the apoptotic marker CASP3. The gene discussed is IL6; the disease is neoplasm.